Delivery Order 36F79719D0169-36C25224F0040

Award Date 12/1/23
Potential Completion Date 11/30/24
Potential Value $649K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Millburn, NJ 07041, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Advanced Accelerator Applications USA Inc. was awarded a $97,386.93 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The delivery order, with a completion date of July 10, 2022, is for the provision of PLUVICTO nuclear medicine to the agency. No set-aside designation was applied to this contract award to supply radiopharmaceutical products in...
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $2,207,437.08 delivery order contract to Advanced Accelerator Applications USA Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA schedule. The prime contractor will provide PLUVICTO to the VA from its place of performance in Millburn, New Jersey. The firm fixed price contract runs from March 16, 2023 through March 15, 2024.</p>
Advanced Accelerator Applications USA Inc. has been awarded a $876,482.37 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. This order was issued against the company's Pharmaceuticals and Drugs Federal Supply Schedule contract to provide the radiopharmaceutical PLUVICTO. No set-aside designation was used for this award. Performance will take place in Millburn, New Jersey with completion by March 15,...
Advanced Accelerator Applications USA Inc. was awarded a $194,773.86 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The firm fixed price order is for the radio-pharmaceutical PLUVICTO and has a period of performance through July 21, 2023. No set-aside provisions were applied to this award made under Master GSA Schedule FSS-61-IB to provide radiopharmaceutical...
Advanced Accelerator Applications USA Inc. was awarded a $97,383.93 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The delivery order, which has no set-aside designation, is for the nuclear medicine PLUVICTO and has a completion date of September 18, 2022. The award draws from the vendor's existing master agreement under GSA Schedule...
Advanced Accelerator Applications USA Inc. was awarded a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The $194,773.86 firm fixed price contract calls for the delivery of PLUVICTO FOR PATIENT to locations in Millburn, New Jersey, in support of VHA pharmaceutical needs. No set-aside provisions were applied to this order placed under Master Contract FSS-61-IB,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 (VA - VHA) awarded a $584,321.58 delivery order contract to Advanced Accelerator Applications USA Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA Schedule. The contract calls for Advanced Accelerator Applications USA Inc. to provide 18 doses of Pluvicto, a radiolabeled PSMA-targeted therapy, for use by veterans receiving care within the VA network. Performance will take...
Advanced Accelerator Applications USA Inc. was awarded a $227,236.17 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The firm fixed price order calls for the delivery of PLUVICTO radio pharmaceutical to the agency's facility in Millburn, New Jersey, with completion by July 1, 2023. No set-aside provisions were applied to this award made under Master Schedule...
Advanced Accelerator Applications USA Inc. has been awarded a $194,773.86 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The firm fixed price order calls for the delivery of six doses of Pluvicto, an emergency radiopharmaceutical drug, to a location in Millburn, New Jersey by October 31, 2022. Issued without a set-aside designation, the award draws from GSA...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 12 to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of the radiopharmaceutical PLUVICTO from March to December 2023, with a potential value of $2,338,693.31. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $649,246 delivery order contract to Advanced Accelerator Applications USA Inc. to provide PLUVICTO radiopharmaceuticals. As the prime contractor, Advanced Accelerator Applications USA Inc. will deliver the pharmaceutical products to locations in Millburn, New Jersey under the one-year firm fixed price contract running from December 2023 through November 2024. The contract was awarded against the company's Pharmaceuticals and Drugs schedule contained within the General Services Administration Multiple Award Schedule. No subcontractors or set-aside designations were identified. The radiopharmaceutical products are likely intended to support nuclear medicine procedures for patients within the VA healthcare system served by VISN 12.

Generated 12/17/23, 9:37 PM